Cargando…
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression
BACKGROUND: Cancer immunotherapy has revolutionized cancer treatment. However, considering the limited success of immunotherapy to only some cancer types and patient cohorts, there is an unmet need for developing new treatments that will result in higher response rates in patients with cancer. Immun...
Autores principales: | Mandel, Ilana, Haves Ziv, Dana, Goldshtein, Ilana, Peretz, Tsuri, Alishekevitz, Dror, Fridman Dror, Anna, Hakim, Motti, Hashmueli, Sharon, Friedman, Itay, Sapir, Yair, Greco, Rita, Qu, Hongjing, Nestle, Frank, Wiederschain, Dmitri, Pao, Lily, Sharma, Sharad, Ben Moshe, Tehila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472153/ https://www.ncbi.nlm.nih.gov/pubmed/36096532 http://dx.doi.org/10.1136/jitc-2022-004859 |
Ejemplares similares
-
Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis
por: Haves-Zburof, Dana, et al.
Publicado: (2011) -
Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach
por: Benguigui, Madeleine, et al.
Publicado: (2017) -
BND-VGG-19: A deep learning algorithm for COVID-19 identification utilizing X-ray images
por: Cao, Zili, et al.
Publicado: (2022) -
Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance
por: ZHANG, YI, et al.
Publicado: (2012) -
Gene‐editing of the strigolactone receptor BnD14 confers promising shoot architectural changes in Brassica napus (canola)
por: Stanic, Matija, et al.
Publicado: (2021)